Boston- and Shenzhen-based XtalPi, which uses AI for drug discovery and development, raises $319M Series C led by SoftBank's Vision Fund (Devin Coldewey/TechCrunch)

Devin Coldewey / TechCrunch:
Boston- and Shenzhen-based XtalPi, which uses AI for drug discovery and development, raises $319M Series C led by SoftBank's Vision Fund  —  XtalPi, an American-Chinese biotech firm that focuses on AI-assisted drug discovery, has raised a $319 million round C from a slate of enthusiastic investors led by SoftBank's Vision Fund.